Importance of D1 and D2 receptors in the dorsal caudate-putamen for the locomotor activity and stereotyped behaviors of preweanling rats

Neuroscience

Volumn 183, Issue , 2011, Pages 121-133

  Charntikov, S ^a   Der Ghazarian, T ^a   Herbert, M S ^a   Horn, L R ^a   Widarma, C B ^a   Gutierrez, A ^a   Varela, F A ^a   Mcdougall, S A ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Caudate putamen; Locomotor activity; Ontogeny; Quinpirole; SKF 82958; Stereotypy

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; QUINPIROLE; RACLOPRIDE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; FEMALE; HABITUATION; HISTOPATHOLOGY; LOCOMOTION; MALE; MOTOR PERFORMANCE; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PUTAMEN; RAT; SNIFFING; STEREOTYPY; THERMOREGULATION; WEANING;

ANIMALS; ANIMALS, NEWBORN; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; EXPLORATORY BEHAVIOR; FEMALE; MALE; MOTOR ACTIVITY; NEOSTRIATUM; NEURAL PATHWAYS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; STATISTICS, NONPARAMETRIC; STEREOTYPED BEHAVIOR;

EID: 79955593553     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.03.037     Document Type: Article

References (59)

1. Abrams D.R., Bruno J.P. Ontogeny of apomorphine-induced stereotypy and its D1 and D2 receptor mediation in rats depleted of dopamine as neonates. Dev Psychobiol 1992, 25:475-495.
2. Adriani W., Laviola G. A unique hormonal and behavioral hyporesponsivity to both forced novelty and d-amphetamine in periadolescent mice. Neuropharmacology 2000, 39:334-346.
3. Allen L.F., Winn P. Excitotoxic lesions of the pedunculopontine tegmental nucleus disinhibit orofacial behaviours stimulated by microinjections of d-amphetamine into rat ventrolateral caudate-putamen. Exp Brain Res 1995, 104:262-274.
4. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity?. Neurosci Biobehav Rev 2003, 27:3-18.
5. Bordi F., Carr K.D., Meller E. Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens. Brain Res 1989, 489:205-215.
6. Bordi F., Meller E. Enhanced behavioral stereotypies elicited by intrastriatal injection of D1 and D2 dopamine agonists in intact rats. Brain Res 1989, 504:276-283.
7. Byrnes E.M., Bruno J.P. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates. Dev Psychobiol 1994, 27:409-424.
8. Cameron D.L., Crosbie J., Crocker A.D. A fixed interval momentary sampling method for assessing on-going behaviours induced by dopamine receptor agonists. Prog Neuro-Psychopharmacol Biol Psychiatry 1988, 12:595-606.
9. Camp L.L., Rudy J.W. Behavioral activation in infant rats: pharmacological evidence for dopaminergic mediation. Psychobiology 1987, 15:317-328.
10. Canales J.J., Gilmour G., Iversen S.D. The role of nigral and thalamic output pathways in the expression of oral stereotypies induced by amphetamine injections into the striatum. Brain Res 2000, 856:176-183.
11. Canales J.J., Iversen S.D. Behavioural topography in the striatum: differential effects of quinpirole and d-amphetamine microinjections. Eur J Pharmacol 1998, 362:111-119.
12. Canales J.J., Iversen S.D. Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors. Synapse 2000, 36:297-306.
13. Carr G.D., White N.M. The relationship between stereotypy and memory improvement produced by amphetamine. Psychopharmacology 1984, 82:203-209.
14. Carrera P.M., Brunhara F.C., Schwarting R.K., Tomaz C. Drug conditioning induced by intrastriatal apomorphine administration. Brain Res 1998, 790:60-66.
15. Charntikov S., Halladay L.R., Herbert M.S., Marquez E.M., McDougall S.A. Effects of dorsal striatal infusions of R(-)-propylnorapomorphine (NPA) on κ-opioid-mediated locomotor activity in the young rat: possible role of the indirect pathway. Neuroscience 2008, 155:603-612.
16. Cortez A.M., Charntikov S., Der-Ghazarian T., Horn L.R., Crawford C.A., McDougall S.A. Age-dependent effects of κ-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study. Neuroscience 2010, 169:203-213.
17. Creese I., Iversen S.D. Blockage of amphetamine-induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 1973, 55:369-382.
18. Delfs J.M., Kelley A.E. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 1990, 39:59-67.
19. Delfs J.M., Schreiber L., Kelley A.E. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J Neurosci 1990, 10:303-310.
20. Dias F.R., Carey R.J., Carrera M.P. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D2 receptor activation is critical but not the expression of the unconditioned response. Brain Res 2006, 1083:85-95.
21. Dickson P.R., Lang C.G., Hinton S.C., Kelley A.E. Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study. Neuroscience 1994, 61:81-91.
22. Dreher J.K., Jackson D.M. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res 1989, 487:267-277.
23. Dunn O.J. Multiple comparisons using rank sums. Technometrics 1964, 5:241-252.
24. Goldman M.E., Kebabian J.W. Aporphine enantiomers. Interactions with D-1 and D-2 dopamine receptors. Mol Pharmacol 1984, 25:18-23.
25. Gong W., Neill D.B., Lynn M., Justice J.B. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience 1999, 93:1349-1358.
26. Hauber W., Münkle M. Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen. Eur J Pharmacol 1997, 323:127-131.
27. Holson R.R., Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol 1992, 14:221-228.
28. Ikemoto S. Ventral striatal anatomy of locomotor activity induced by cocaine, d-amphetamine, dopamine and D1/D2 agonists. Neuroscience 2002, 113:939-955.
29. Kelley A.E., Lang C.G., Gauthier A.M. Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacology 1988, 95:556-559.
30. Koene P., Prinssen E.P., Cools A.R. Involvement of the nucleus accumbens in oral behaviour in the freely moving rat. Eur J Pharmacol 1993, 233:151-156.
31. Kreipke C.W., Walker P.D. NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation. Synapse 2004, 53:28-35.
32. Krolewski D.M., Bishop C., Walker P.D. Intrastriatal dopamine D1 receptor agonist-mediated motor behavior is reduced by local neurokinin 1 receptor antagonism. Synapse 2005, 57:1-7.
33. McDougall S.A., Arnold T.F., Nonneman A.J. Ontogeny of locomotor activity and grooming in the young rat: role of dopamine D1 and D2 receptors. Eur J Pharmacol 1990, 186:223-230.
34. Meller E., Bohmaker K., Namba Y., Friedhoff A.J., Goldstein M. Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Mol Pharmacol 1987, 31:592-598.
35. Meyer M.E. Effects of intraaccumbens dopamine agonist SK&F38393 and antagonist SCH23390 on locomotor activities in rats. Pharmacol Biochem Behav 1993, 45:843-847.
36. Meyer M.E., Van Hartesveldt C., Potter T.J. Locomotor activity following intra-accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats. Synapse 1993, 13:310-314.
37. Mogenson G.J., Wu M. Effects of administration of dopamine D2 agonist quinpirole on exploratory locomotion. Brain Res 1991, 551:216-220.
38. Moody C.A., Spear L.P. Ontogenetic differences in the psychopharmacological responses to separate and combined stimulation of D1 and D2 dopamine receptors during the neonatal to weanling age period. Psychopharmacology 1992, 106:161-168.
39. Morelli M., Porceddu M.L., Di Chiara G. Lesions of substantia nigra by kainic acid: effects on apomorphine-induced stereotyped behaviour. Brain Res 1980, 191:67-78.
40. Neisewander J.L., Fuchs R.A., O'Dell L.E., Khroyan T.V. Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion. Synapse 1998, 30:194-204.
41. Neisewander J.L., O'Dell L.E., Redmond J.C. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion. Brain Res 1995, 671:201-212.
42. O'Boyle K.M., Gaitanopoulos D.E., Brenner M., Waddington J.L. Agonist and antagonist properties of benzazepine and thienpyridine derivatives at the D1 dopamine receptor. Neuropharmacology 1989, 28:401-405.
43. Paxinos G., Watson C. The rat brain: in stereotaxic coordinates 1998, Academic Press, San Diego. 4th ed.
44. Plaznik A., Stefanski R., Kostowski W. Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity. Psychopharmacology 1989, 99:558-562.
45. Schildein S., Ågmo A., Huston J.P., Schwarting R.K. Intraaccumbens injections of substance P, morphine and amphetamine: effects on conditioned place preference and behavioral activity. Brain Res 1998, 790:185-194.
46. Setler P.E., Sarau H.M., Zirkle C.L., Saunders H.L. The central effects of a novel dopamine agonist. Eur J Pharmacol 1978, 50:419-430.
47. Shalaby I.A., Spear L.P. Psychopharmacological effects of low and high doses of apomorphine during ontogeny. Eur J Pharmacol 1980, 67:451-459.
48. Sherwood N.M., Timiras P. A stereotaxic atlas of the developing rat brain 1970, University of California Press, Berkeley.
49. Shieh G.-J., Walters D.E. Stimulating dopamine D1 receptors increases the locomotor activity of developing rats. Eur J Pharmacol 1996, 311:103-107.
50. Siegel S., Castellan N.J. Nonparametric statistics for the behavioral sciences 1988, McGraw-Hill, Boston. 2nd ed.
51. Sobrian S.K., Jones B.L., Varghese S., Holson R.R. Behavioral response profiles following drug challenge with dopamine receptor subtype agonists and antagonists in developing rat. Neurotoxicol Teratol 2003, 25:311-328.
52. Spear L.P. The use of psychopharmacological procedures to analyse the ontogeny of learning and retention: issues and concerns. Ontogeny of learning and memory 1979, 135-156. Lawrence Erlbaum Associates, Hillsdale, NJ. N.E. Spear, B.A. Campbell (Eds.).
53. Spear L.P., Brake S.C. Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats. Dev Psychobiol 1983, 16:83-109.
54. Staton D.M., Solomon P.R. Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat. Physiol Psychol 1984, 12:159-162.
55. Swanson C.J., Heath S., Stratford T.R., Kelley A.E. Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacol Biochem Behav 1997, 58:933-945.
56. Van Hartesveldt C., Cottrell G.A., Potter T., Meyer M.E. Effects of intracerebral quinpirole on locomotion in rats. Eur J Pharmacol 1992, 214:27-32.
57. Van Hartesveldt C., Meyer M.E., Potter T.J. Ontogeny of biphasic locomotor effects of quinpirole. Pharmacol Biochem Behav 1994, 48:781-786.
58. Waszczak B.L., Martin L.P., Finlay H.E., Zahr N., Stellar J.R. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia. J Pharmacol Exp Ther 2002, 300:850-861.
59. Zorrilla E.P. Multiparous species present problems (and possibilities) to developmentalists. Dev Psychobiol 1997, 30:141-150.